SmileDirectClub Stock Has Short Squeeze Potential
Published
Published
The biotech stock, which has had a volatile year, is a favorite of retail investors because of its potential for a short squeeze.
The stock has a 34% short-interest rate with less than two days to cover, Fintel.io data show.